Thursday, March 12, 2026

NASTAD Releases 2026 ADAP Monitoring Report: Warning Signs Ahead

›
By:  Marcus J. Hopkins , Health Policy Lead Consultant, ADAP Advocacy The National Alliance of State and Territorial AIDS Directors (NASTARD...
Thursday, March 5, 2026

The Medical Monopolies Monopolizing Modern Medicine

›
By:  Marcus J. Hopkins , Health Policy Lead Consultant, ADAP Advocacy Imagine a scenario where every aspect of your healthcare is owned by t...
Thursday, February 26, 2026

Medicare Drug Price Negotiations Again Target High-Impact Prescriptions, But at what Cost?

›
By:  Marcus J. Hopkins , Health Policy Lead Consultant, ADAP Advocacy The Trump Administration recently released the next round of medicati...
Thursday, February 19, 2026

Florida, Once Again, Imperils the Lives of People Living with HIV/AIDS

›
By:  Marcus J. Hopkins , Health Policy Lead Consultant, ADAP Advocacy The state of Florida is in the process of revamping [deconstructing] i...
Thursday, February 12, 2026

Why Modifying Protected Drug Classes Creates a Slippery Slope for Patients Living with HIV

›
By: Scott Bertani , Director of Advocacy at HealthHIV As a Person living with HIV who was diagnosed in Denver in the mid-1990s, during a per...
Thursday, February 5, 2026

Are 340B Covered Entities Sacrificing Affordable Care for Executive Compensation?

›
By: Brandon M. Macsata , CEO, ADAP Advocacy, Guy Anthony , Chair, ADAP Advocacy 340B Patient Advisory Committee, and  Marcus J. Hopkins , He...